LINE-1 and Alu Methylation in hrHPV-Associated Precancerous Cervical Samples. Chaiwongkot A, Buranapraditkun S, Chujan S, Kitkumthorn N. Asian Pac J Cancer Prev. 2022 Oct 1;23(10):3443-3448.

01 Oct 2022
0
0

LINE-1 and Alu Methylation in hrHPV-Associated Precancerous Cervical Samples.

Chaiwongkot A, Buranapraditkun S, Chujan S, Kitkumthorn N.

Asian Pac J Cancer Prev. 2022 Oct 1;23(10):3443-3448.

Tags

Share this

Related Posts

Translational Proteomic Approach for Cholangiocarcinoma Biomarker Discovery, Validation, and Multiplex Assay Development: A Pilot Study. Watcharatanyatip K., Chutipongtanate S., Chokchaichamnankit D., Weeraphan C., Mingkwan K., Luevisadpibul V., Newburg D.S., Morrow A.L., Svasti J. and Srisomsap C. Molecules. 2022 Sep;27(18):5904.
11 Sep 2022
0

Translational Proteomic Approach for Cholangiocarcinoma Biomarker Discovery, Validation, and Multiplex Assay Development: A Pilot Study. Watcharatanyatip K., Chutipongtanate S., Chokchaichamnankit D., Weeraphan C., Mingkwan K., Luevisadpibul V., Newburg D.S., Morrow A.L., Svasti J. and Srisomsap C. Molecules. 2022 Sep;27(18):5904.

Translational Proteomic Approach for Cholangiocarcinoma Biomarker Discovery, Validation, and Multiplex Assay Development: A Pilot Study Translational Proteomic Approach for Cholangiocarcinoma Biomarker Discovery, Validation, and Multiplex Assay Development: A Pilot Study. Watcharatanyatip K., Chutipongtanate S., Chokchaichamnankit D., Weeraphan C., Mingkwan K., Luevisadpibul V., Newburg D.S., Morrow A.L., Svasti J. and Srisomsap C. Molecules. 2022 Sep;27(18):5904.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More